SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:1420 8008 "

Sökning: L773:1420 8008

  • Resultat 31-40 av 290
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
31.
  • Blom, Elin S., et al. (författare)
  • Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype.
  • 2009
  • Ingår i: Dementia and geriatric cognitive disorders. - : S. Karger AG. - 1421-9824 .- 1420-8008. ; 27:5, s. 458-64
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND/AIMS: Increased cerebrospinal fluid (CSF) tau, decreased CSF amyloid-beta42 (Abeta42) and the apolipoprotein E gene (APOE) epsilon4 allele predict progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD). Here, we investigated these markers to assess their predictive value and influence on the rate of disease progression. METHODS: Using ELISA, we measured the CSF biomarkers in 47 AD patients, 58 patients with MCI and 35 healthy control subjects. Twenty-eight MCI patients revisited the clinic and half of them progressed to AD during a period of 3-12 years. RESULTS: The expected changes in CSF total (T)-tau, phosphorylated (P)-tau and Abeta42 levels were found in AD, confirming the diagnostic value of these biomarkers. We were also able to corroborate an increased risk for progression from MCI to AD with elevated CSF T-tau and P-tau and with the presence of the APOE epsilon4/epsilon4 genotype, but not with decreased Abeta42. Finally, for the first time we demonstrated that MCI subjects with high CSF T-tau or P-tau and APOE epsilon4 homozygosity progressed faster from MCI to AD. CONCLUSIONS: CSF T-tau and P-tau as well as the APOE epsilon4/epsilon4 genotype are robust predictors of AD and are also associated with a more rapid progression from MCI to AD.
  •  
32.
  • Blomberg, M, et al. (författare)
  • Cerebrospinal fluid tau levels increase with age in healthy individuals
  • 2001
  • Ingår i: Dementia and geriatric cognitive disorders. - : S. Karger AG. - 1420-8008 .- 1421-9824. ; 12:2, s. 127-132
  • Tidskriftsartikel (refereegranskat)abstract
    • Cerebrospinal fluid (CSF) tau is a promising biochemical ante-mortem marker for Alzheimer’s disease (AD). Levels are increased in AD compared to other dementias, neurological diseases and healthy controls. An age-related decrease in both soluble tau and tau bound to paired helical filaments has been shown in brains from non-demented subjects. To study tau levels in normal ageing, we investigated CSF in 29 healthy individuals aged 45–80 years. A statistically significant increase in CSF tau with increasing age was found which might be caused by neuronal loss during normal ageing and redistribution of soluble tau from the brain into CSF. We could not demonstrate any influence by the APOE genotype, though larger populations have to be investigated to confirm this result. In conclusion, we found an age-dependent increase in CSF tau in healthy individuals. We emphasise the importance of establishing an age-dependent interval of CSF tau in non-demented subjects.
  •  
33.
  •  
34.
  • Bogdanovic, N, et al. (författare)
  • The Swedish APP670/671 Alzheimer's disease mutation: the first evidence for strikingly increased oxidative injury in the temporal inferior cortex
  • 2001
  • Ingår i: Dementia and geriatric cognitive disorders. - : S. Karger AG. - 1420-8008 .- 1421-9824. ; 12:6, s. 364-370
  • Tidskriftsartikel (refereegranskat)abstract
    • To evaluate the level of oxidative stress (OS) in familial Alzheimer’s disease (FAD), we analysed four cerebrocortical areas from patients with Swedish FAD bearing the APP670/671 mutation. The temporal inferior cortex (TIC) from Swedish FAD patients revealed a striking 2- to 3-fold increase in diene conjugates, lipid peroxides and protein carbonyls, compared to sporadic Alzheimer’s disease (AD). Compared with TIC from sporadic AD patients, the mutation carriers showed a markedly decreased activity of catalase (CAT) in the same area, and the same trend was found for another antioxidant enzyme, superoxide dismutase. These results are consistent with the deep oxidative injury of TIC in Swedish FAD. In the frontal inferior cortex (FIC), sensory postcentral cortex (SPCC) and occipital primary cortex (OPC) from Swedish FAD, the parameters of oxidative injury tended to be higher than in sporadic AD. Only the increase in the levels of lipid hydroperoxides in SPCC and of protein carbonyls in OPC was significant. Compared to sporadic AD, Swedish FAD showed a significant increase in GSSG levels and the GSSG/2GSH ratio in the FIC, SPCC and OPC. A significantly decreased activity of CAT was detectable for the SPCC and OPC in Swedish FAD. Increased OS might play a crucial role in the rapid progression of Swedish FAD from the associative temporal cortex to the primary cerebrocortical areas.
  •  
35.
  • Borda, MG, et al. (författare)
  • Timed Up and Go in People with Subjective Cognitive Decline Is Associated with Faster Cognitive Deterioration and Cortical Thickness
  • 2022
  • Ingår i: Dementia and geriatric cognitive disorders. - : S. Karger AG. - 1421-9824 .- 1420-8008. ; 51:1, s. 63-72
  • Tidskriftsartikel (refereegranskat)abstract
    • <b><i>Introduction:</i></b> Early markers of neurodegeneration provide an opportunity to detect, monitor, and initiate interventions in individuals who have an increased risk of developing dementia. Here, we investigated whether the Timed Up and Go (TUG) test is associated with early brain neurodegeneration and whether the TUG test could be a marker of cognitive decline in people with subjective cognitive decline (SCD). <b><i>Methods:</i></b> This is a longitudinal analysis of the Dementia Disease Initiation Study, a prospective, community-based, cohort study from Norway, designed to investigate early markers of cognitive impairment and dementia. Participants were classified as SCD and healthy controls (HC). The main studied variables were the TUG test and cognition as measured by the Mini-Mental State Examination and the Consortium to Establish a Registry for Alzheimer’s Disease memory composite score. Additionally, we investigated the cross-sectional association of brain morphology with the TUG using 1.5T-MRI. <b><i>Results:</i></b> The sample included 45 participants (SCD = 21, HC = 24) followed during a mean time of 1.50 ± 0.70 years. At baseline, the cognitive performance did not differ between the groups, but TUG was longer in SCD. Slower baseline TUG was associated with a faster cognitive decline in both groups and it was also associated with reduced cortical thickness especially in motor, executive, associative, and somatosensory cortical regions in people with SCD. <b><i>Discussion/Conclusion:</i></b> TUG predicted cognitive change in individuals with SCD, and there was a negative association between TUG and cortical thickness. TUG is a promising cheap and noninvasive marker of early cognitive decline and may help initiate interventions in individuals who have an increased risk of dementia.
  •  
36.
  • Boström, Fredrik, et al. (författare)
  • Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies.
  • 2009
  • Ingår i: Dementia and geriatric cognitive disorders. - : S. Karger AG. - 1421-9824 .- 1420-8008. ; 28:4, s. 314-9
  • Tidskriftsartikel (refereegranskat)abstract
    • A pathology typical of dementia with Lewy bodies (DLB) has been demonstrated to increase mortality to a greater extent than the pathology of Alzheimer's disease (AD). However, mortality in DLB has also been shown to increase with concomitant AD pathology. Furthermore, in a recent publication, we showed that there is a robust and specific increase in CSF calcium and magnesium in DLB patients compared to both AD patients and controls. Thus, in order to explore the influence of CSF AD markers and trace element concentrations on mortality in DLB, we undertook a longitudinal prospective study of 47 clinically diagnosed DLB patients and 157 AD patients as well as 49 healthy volunteers. Both AD and DLB patients showed an increased mortality compared to the healthy controls (relative risk: 10 and 8, respectively; p < 0.001). Increased levels of CSF total tau were associated with increased mortality among the DLB patients (p < 0.05), but not among the AD patients or controls. Gender, age, MMSE score, Abeta42 concentration and phosphorylated tau, and CSF trace element concentrations did not influence survival in the obtained models.
  •  
37.
  • Bramell-Risberg, Eva, et al. (författare)
  • Lower Gait Speed in Older Women with Dementia Compared with Controls.
  • 2005
  • Ingår i: Dementia and Geriatric Cognitive Disorders. - : S. Karger AG. - 1420-8008 .- 1421-9824. ; 20:5, s. 298-305
  • Tidskriftsartikel (refereegranskat)abstract
    • Movement time is increased in patients with Alzheimer’s disease. <i>Objectives:</i> To study differences in movement time and ability to increase speed in older women with dementia. <i>Methods:</i> Four tests were performed at self-selected and maximal speed: walking 2 ×15 m, walking between parallel lines, ‘get up and go’ (GUG) and rising from lying supine. Twenty-two patients and 22 controls (mean ages 81 and 86 years, respectively) were included in the study. <i>Results:</i> In the groups over 80 years, walking and GUG at both speeds and rising from lying supine from the left at self-selected speed were significantly slower among patients (20–30%). Both patients and controls were able to increase movement speed when changing from self-selected to maximal speed (13–27%). Patients with Alzheimer’s disease had lower self-selected walking speed compared with patients with other types of dementia (p = 0.048). <i>Conclusion:</i> Testing physical performance in two different speeds was feasible in patients with dementia. Patients had slower gait speed and were slower in the functional tests, such as GUG, but the capacity to increase speed seemed intact.
  •  
38.
  • Bramell-Risberg, Eva, et al. (författare)
  • Slowing of Alternating Forearm Movements Is Associated with Cognitive Impairment in Community-Dwelling Older People.
  • 2010
  • Ingår i: Dementia and Geriatric Cognitive Disorders. - : S. Karger AG. - 1420-8008 .- 1421-9824. ; 29:5, s. 457-466
  • Tidskriftsartikel (refereegranskat)abstract
    • Background/Aims: Motor impairment is an important aspect of cognitive decline in older adults. It has been suggested that complex motor control is affected earlier than gross motor control. The aims were to investigate if complex hand motor function was more affected than gross motor function in cognitively impaired older subjects, and to present reference values. Methods: Alternating forearm movements and grip strength were studied in 301 cases, 419 intermediates and 1,207 controls, aged 60-93 years, controlling for demographic, health-related and functional factors and comorbidity. Global cognitive function was assessed by the Mini-Mental State Examination, and episodic memory by 3-word delayed recall. Grip strength was assessed by the Grippit(R). The frequency of alternating movements during 10 s was registered electronically. Results: Alternating movements but not grip strength was associated with cognitive impairment (right: p = 0.006; left: p = 0.022). The mean alternating movements for the 70-year-old male cases compared to the controls were 2.3 versus 2.5 Hz for the right, and 2.2 versus 2.4 Hz for the left arm (p < 0.05), and for the 60-year-old women 2.0 versus 2.3 Hz for the right arm (p < 0.05). Conclusion: Complex but not gross hand motor function is associated with early cognitive impairment.
  •  
39.
  • Brane, G, et al. (författare)
  • The Gottfries-Bråne-Steen scale: validity, reliability and application in anti-dementia drug trials
  • 2001
  • Ingår i: Dementia and geriatric cognitive disorders. - : S. Karger AG. - 1420-8008 .- 1421-9824. ; 12:1, s. 1-14
  • Tidskriftsartikel (refereegranskat)abstract
    • Neuropsychological investigation using a comprehensive rating scale is important for the diagnosis and evaluation of dementia patients over time. Requirements for such a scale include accuracy, reliability, sensitivity of the scale over the disease course and simplicity for clinical use by a wide range of healthcare professionals. Ideally, the scale should also be capable of assessing the impact of pharmacological and non-pharmacological treatment regimens on the management of dementia patients. The Gottfries-Bråne-Steen (GBS) Scale is a comprehensive global assessment tool for evaluating dementia symptoms and is based on a semi-structured interview and observation of the patient. The scale consists of subscales measuring intellectual (12 items), emotional (3 items) and activities of daily living, primarily items of self-care (6 items); as well as 6 items of behavioral and psychological symptoms of dementia. This review describes the reliability, validity and sensitivity of the most recent version of the GBS scale since its original publication in 1982.
  •  
40.
  • Bronge, L, et al. (författare)
  • Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study
  • 2002
  • Ingår i: Dementia and geriatric cognitive disorders. - : S. Karger AG. - 1420-8008 .- 1421-9824. ; 13:4, s. 205-212
  • Tidskriftsartikel (refereegranskat)abstract
    • To evaluate whether magnetic resonance imaging (MRI) of white matter changes in Alzheimer’s disease either under- or overestimates the findings on neuropathology. Postmortem MRI and neuropathological examination were performed on 6 brains from elderly individuals with a postmortem diagnosis of AD. Using a specially designed brain slicer, the brains were cut corresponding to the MRI images, and stained by Luxol Fast Blue. Quantitative analysis of white matter changes on MRI and neuropathology was performed using stereological principles. Measures from MRI and pathology were highly correlated (r<sup>2</sup> = 0.71). However, pathology showed significantly more extensive changes than did MRI in all cases, with a mean of 54% larger areas. The lesions not identified with MRI represented, however, only minor changes with lower intensity of myelin staining and with an accentuation of the distance between fibres but with preserved axonal network and glial cell density.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 31-40 av 290
Typ av publikation
tidskriftsartikel (275)
konferensbidrag (13)
forskningsöversikt (2)
Typ av innehåll
refereegranskat (278)
övrigt vetenskapligt/konstnärligt (12)
Författare/redaktör
Wahlund, LO (34)
Blennow, Kaj, 1958 (29)
Minthon, Lennart (29)
Gustafson, Lars (27)
Winblad, B (25)
Zetterberg, Henrik, ... (21)
visa fler...
Wallin, Anders, 1950 (19)
Aarsland, D (17)
Londos, Elisabet (16)
Nilsson, Karin (15)
Hultberg, Björn (14)
Lannfelt, L (14)
Almkvist, O (14)
Ballard, C (12)
Kivipelto, M (12)
Soininen, H (11)
Rolstad, Sindre, 197 ... (10)
Hansson, Oskar (10)
Jelic, V (10)
Passant, Ulla (10)
Nordlund, Arto, 1962 (10)
Rongve, A (9)
Nordberg, A (9)
Elmståhl, Sölve (8)
Wahlund, Lars-Olof (8)
Lannfelt, Lars (8)
Fratiglioni, L (8)
Englund, Elisabet (8)
Marcusson, Jan, 1958 ... (8)
Edman, Åke (8)
Almkvist, Ove (7)
BOGDANOVIC, N (7)
Engedal, K (7)
Kilander, Lena (7)
Wattmo, Carina (7)
Bogdanovic, Nenad (6)
Blennow, K (6)
Julin, P (6)
Ostberg, P (6)
Basun, H (6)
Brun, Arne (6)
Warkentin, Siegbert (6)
Nägga, Katarina (6)
Rosén, Ingmar (5)
Graff, C (5)
Nissinen, A (5)
Waldemar, G (5)
Eckerström, Carl (5)
Lind, Karin, 1952 (5)
Göthlin, Mattias, 19 ... (5)
visa färre...
Lärosäte
Karolinska Institutet (161)
Lunds universitet (79)
Göteborgs universitet (50)
Stockholms universitet (23)
Uppsala universitet (20)
Linköpings universitet (18)
visa fler...
Umeå universitet (11)
Örebro universitet (8)
Linnéuniversitetet (6)
Röda Korsets Högskola (4)
Jönköping University (2)
Kungliga Tekniska Högskolan (1)
Luleå tekniska universitet (1)
Högskolan Dalarna (1)
visa färre...
Språk
Engelska (290)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (139)
Samhällsvetenskap (12)
Naturvetenskap (3)
Humaniora (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy